Some RNPs such as RBM3, IMP3, and CUG-BP1 facilitate the formation of drug resistance 22 while heterogeneous nuclear ribonucleoprotein K has been associated with cancer procession and high risk of metastasis 23. This evidence concerns the gene RBM3 and cancer.